Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
06/2003
06/04/2003EP1315417A2 Mutant non-human mammal for expressing the alpha6 acetylcholine nicotinic receptor subunit and use for screening substances capable of interacting with said receptor
06/04/2003EP1315416A2 Method of obtaining a non-human mammal susceptible to adenovirus-mediated gene delivery
06/04/2003EP1315411A2 PROTOCOLS FOR THE GENERATION OF HIGH YIELD, SUPER-PRODUCTIVE TRANSGENIC PLANTS DISTURBED IN Ran/Ran-BINDING PROTEINS-MEDIATED CELLULAR PROCESS
06/04/2003EP1196444B1 Extendin-4 conjugates and their medical use
06/04/2003EP1185624A4 Process of expressing and isolating recombinant proteins and recombinant protein products from plants, plant derived tissues or cultured plant cells
06/04/2003EP1151299A4 Method of site specific labeling of proteins and uses therefor
06/04/2003EP1143997B1 Tumor necrosis factor antagonists and their use in endometriosis treatment
06/04/2003EP1025203A4 Impaired brca2 function in cells and non-human transgenic animals
06/04/2003EP0929577B1 Stabilized proteinaceous protease inhibitors and variants thereof
06/04/2003EP0917470B1 Composition containing a dried animal stomach mucosa, process for preparing said composition and use thereof
06/04/2003EP0862581B1 Heparin chromatography of erythropoietins
06/04/2003EP0859838B1 Novel procollagens
06/04/2003EP0716695B1 Human calcium channel compositions and methods using them
06/04/2003EP0692028B1 Pharmaceuticals based on papillomaviruses
06/04/2003EP0672116B1 Deletion mutants as vaccines for cholera
06/04/2003EP0670730B1 Fusion protein comprising two tumor necrosis factor receptors
06/04/2003EP0658201B1 Dna sequences involved in soraphen biosynthesis by myxobacteria
06/04/2003EP0656007B1 Delta opioid receptor genes
06/04/2003EP0571602B1 Dimer of molecular variant of apolipoprotein and processes for the production thereof
06/04/2003CN1422334A Ecdysone receptor-based inducible gene expression system
06/04/2003CN1422281A G-protein coupled receptors
06/04/2003CN1422280A Novel collagen-like protein CLAC, Precursor thereof and genes encoding the same
06/04/2003CN1421461A Fusion protein with reinforced erythrocytin activity in vivo
06/04/2003CN1421458A Prepn of fat-free hematoglobin
06/04/2003CN1421457A New human protein with cancer cell growth inhibiting function and its coding sequence
06/04/2003CN1110564C Adenovirus without viable contaminant particle, preparation and use thereof
06/04/2003CN1110559C Gene for regulating aureobasidin sensitivity
06/04/2003CN1110558C Novel growth/differentiation factor of the TGF-ÔÇÿbetaÔÇÖfamily
06/04/2003CN1110557C LAG-3 protein soluble polypeptide fractions, method of production, therapeutic composition and anti-idio type antibody
06/04/2003CN1110556C Isolated nucleic acid molecules for coding tumor rejection antigen precursor MAGE-3 and use thereof
06/04/2003CN1110503C Isolated, truncated nucleicacid molecules of codeed GAGE tumor exclusion antigen
06/03/2003US6573437 Acala variety using DNA which confers a phenotype (antibiotic/herbicide/glyphosate resistance); growing in a sucrose-free callus induction medium comprising glucose; transferring to a glucose-free, sucrose medium
06/03/2003US6573432 Regulation of anthocyanin pigment production
06/03/2003US6573430 Cen gene and a method for delaying flowering
06/03/2003US6573428 Chimeric gene comprising a transcription regulatory sequence linked to a heterologous nucleic acid sequence; filament of stamen; tissue-specific
06/03/2003US6573371 Cell growth inhibiting and cell differentiation specific SYG972 gene, genomic DNA and promoter thereof
06/03/2003US6573368 Compositions for the treatment and diagnosis of breast cancer and methods for their use
06/03/2003US6573366 Loading the mixture onto a cationic exchange matrix and eluting with a buffered solution; applying onto an anionic exchange matrix, eluting and recovering
06/03/2003US6573365 Of given amino acid sequence; Nuclear Factor of Activated T Cells (NF-AT); can use in identifying agents that modulate their activity
06/03/2003US6573364 Isolation and characterization of Hermansky Pudlak Syndrome (HPS) protein complexes and HPS protein-interacting proteins
06/03/2003US6573363 Isolated polypeptide of given amino acid sequence; may be useful in the treatment of diseases characterized by overexpression of glycoprotein hormone; can use in diagnosis, treatment or prevention of cancer and diabetes
06/03/2003US6573362 Of given amino acid sequence; binding inhibition; can use in reducing or influencing inflammations, improving wound healing, suppressing theimmune system for organ transplants, preventing metastasis of tumors and treating arteriosclerosis
06/03/2003US6573360 Human ABH
06/03/2003US6573244 Previns as specific inhibitors and therapeutic agents for Botulinum toxin B and Tetanus neurotoxins
06/03/2003US6573243 Pompilid wasp-derived neuropeptides
06/03/2003US6573240 Controlling lepidopteran insect pests by contacting with effective amount of toxin comprising insecticidal fragment of specified amino acid sequence
06/03/2003US6573239 Compound comprising 15 to 26-residue peptide or peptide analogue which forms amphipathic alpha-helix in presence of lipids and exhibits specified lecithin:cholesterol acyltransferase activation activity
06/03/2003US6573236 Myelin oligodendrocyte glycoprotein (MOG) polypeptide-specific antibody to bind a natural MOG polypeptide and competitively inhibit the binding of an autoantibody, does not comprise functional Fc portion; multiple sclerosis
06/03/2003US6573100 DNA vectors without a selection marker gene
06/03/2003US6573098 Nucleic acid libraries
06/03/2003US6573096 Continuous cell lines which produce monospecific antibodies that specifically bind an epitope of a human dipeptidyl peptidase IV and thereby inhibit angiogenesis; use in treatment of cancer
06/03/2003US6573095 Polynucleotides isolated from skin cells
06/03/2003US6573094 F-box genes and proteins
06/03/2003US6573093 Temperature sensitive plasmids of P. haemolytica
06/03/2003US6573091 Provide efficient and less harmful transmission of genetic vectors by retroviral particles; nucleic acid sequences; use to transmit genetic material for gene therapy, cell therapy, or other biotechnological applications
06/03/2003US6573082 Streptococcus pneumoniae antigens and vaccines
06/03/2003US6573079 Methods and interferon deficient substrates for the propagation of viruses
06/03/2003US6573078 Human immunodeficiency virus (HIV) protein fragments having antiviral activity; peptides derived from HIV transmembrane glycoprotein that inhibit HIV-induced cell-cell fusion; use for inhibition of enveloped viral infection
06/03/2003US6573073 Oligonucleotide regulatory sequence that increases promoter activity; vectors; gene therapy for cystic fibrosis; cystic fibrosis transmembrane conductance regulator (CFTR)
06/03/2003US6573071 Given amino acid sequence with a modification resulting in a different processing site; use in treating blood disorders
06/03/2003US6573070 DNA molecules encoding the melanocortin 4 receptor protein from rhesus monkey
06/03/2003US6573069 Crib protein ZMSE1
06/03/2003US6573068 Claudin-50 protein
06/03/2003US6573067 Nucleic acid encoding sodium channels in dorsal root ganglia
06/03/2003US6573066 FtsH from Staphylococcus aureus
06/03/2003US6573059 DNA construct for the preparation of a fusion protein; green fluorescent protein
06/03/2003US6573058 Which binds immunospecifically; encoded by a cDNA contained within a plasmid; can use to develop antiviral drugs that block entry into cells
06/03/2003US6573057 Pain therapy; modulator of gene expression
06/03/2003US6573056 Process for purifying factor VII and activated factor VII
06/03/2003US6573041 Determining reactivation, induction and suppression of virus latency
06/03/2003US6573003 Soluble recombinant fusion protein comprising a nontoxin protein sequence and portion of Clostridium difficile toxin B amino acid sequence 10; pseudomembranous enterocolitis; side effect free; low cost
06/03/2003US6572865 Mycobacterium tuberculosis DNA sequences encoding immunostimulatory peptides and methods for using same
06/03/2003US6572864 Nucleotide and deduced amino acid sequences of the envelope 1 gene of 51 isolates of hepatitis C virus and the use of reagents derived from these sequences in diagnostic methods and vaccines
06/03/2003US6572863 Genome is modified to disable VPR and TAT to prevent their expression; stop codons to prevent translation
06/03/2003US6572862 Methods and reagents to detect and characterize Norwalk and related viruses
06/03/2003US6572860 ICP27, glycoprotein B, ribonucleotide reductase, ICP4, ICP34.5, glycoprotein E or glycoprotein F and an immunomodulatory peptide which is a portion of an immunoprotein which promotes binding to a class of T cells and
06/03/2003US6572859 Hypoallergenic polypeptide consisting of an amino acid sequence of SEQ ID NO: 20 and 21; Phl p6 molecule has an N-terminal and/or C-terminal deletion which makes the molecule at least substantially lack IgE binding capacity
06/03/2003US6572853 Recombinant human beta interferon with enhanced solubility
06/03/2003US6572852 Genetic engineering
06/03/2003CA2217633C Genes encoding lymphocyte interferon regulatory factor (lsirf) polypeptides
06/03/2003CA2145523C Polypeptides involved in streptogramineae biosynthesis; nucleotide sequences coding said polypeptides and their use
06/03/2003CA2076424C Phosphoinositol-glycan-peptide with insulin-like action
05/2003
05/30/2003WO2003044535A1 Method, antigen and antibody for distinguishing viable and apoptotic cells
05/30/2003WO2003044214A2 Methods and compositions in checkpoint signaling
05/30/2003WO2003044212A2 Nucleic acids and polypeptides of invertebrate brca2 and methods of use
05/30/2003WO2003044210A2 Process for preparing insulin compounds
05/30/2003WO2003044202A1 Chimeric plasmid comprising a replicative retroviral genome and uses thereof
05/30/2003WO2003044197A1 Huntington’s disease gene transcriptional factors
05/30/2003WO2003044196A1 Postsynaptic proteins
05/30/2003WO2003044192A1 Process for producing l-amino acid using escherichia
05/30/2003WO2003044191A1 Process for producing l-amino acid using escherichia
05/30/2003WO2003044190A1 Environmental stress-responsive promoters and genes encoding transcriptional factor
05/30/2003WO2003044189A1 Nucleotide sequence coding for a modified protein of interest, expression vector and method for obtaining same
05/30/2003WO2003044185A2 Purified polypeptides involved in general metabolism
05/30/2003WO2003044184A1 Treatment of pml targeting jc virus agno
05/30/2003WO2003044182A1 CELLS EXPRESSING gob-5 AND USE THEREOF
05/30/2003WO2003044175A2 Methods and use of motoneuronotropic factors
05/30/2003WO2003044174A2 Mammary-associated serum amyloid a3 promoter sequences and uses for same
05/30/2003WO2003044173A2 Antitumor activity of bok
05/30/2003WO2003044172A2 Composition comprising and method of using angiopoietin-like protein 3 angptl3
1 ... 1595 1596 1597 1598 1599 1600 1601 1602 1603 1604 1605 1606 1607 1608 1609 1610 1611 1612 1613 1614 1615 ... 2916